The Cash Cow in 'Fertility' Medicine
By Pamela M Tsigdinos, Healthcare in America | 10. 23. 2016
On average, the cost of a basic IVF cycle in the U.S ranges from $12,000 — $15,000 yet three out of four times it fails
20 million fails. This is one stat not discussed at the latest American Society for Reproductive Medicine (ASRM) Scientific Congress and Expo. It’s also not posted on fertility clinic member websites nor shared on their social media feeds but it should be.
Last week thousands of physicians, nurses, scientists and lab technicians gathered in Salt Lake City joined by legions of pharmaceutical representatives, ‘fertility’ entrepreneurs and service providers in full on ‘sell mode.’
It’s been nearly 40 years since in vitro fertilization (IVF) became available. There has been explosive growth in the size and scope of clinics and profit taking but no commensurate improvement in IVF outcomes.
Here are five other facts that aren’t widely known but should be:
Fact #1: ‘Fertility’ is now a huge market. That’s right: a market. The global In-Vitro Fertilization (IVF) market size was valued at $9.6 billion in 2014. A more recent report by Grand View Research, Inc. projects the global ...
Related Articles
By Sarah Zhang, The Atlantic | 10.19.2017
And she isn’t the only one.
Last year, a 77-year-old woman traveled to a clinic in Georgia to have stem cells injected in her eyes. She came in hope of a cure—or at least something that could help her macular...
By Jeff Lyon, JAMA | 10.18.2017
As CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats–Cas9) and other gene-editing technologies hasten the feasibility of effective somatic and germline genomic manipulation, an international panel of genetics groups has weighed in on some of the thorniest ethical and scientific implications...
By Liz Szabo, Kaiser Health News | 10.17.2017
Outrage over the high cost of cancer care has focused on skyrocketing drug prices, including the $475,000 price tag for the country’s first gene therapy, Novartis’ Kymriah, a leukemia treatment approved in August.
But the total costs of...
By Kristen V. Brown, Gizmodo | 10.18.2017
You probably wouldn’t hand out your social security number without having a pretty good idea of how that information was going to be used, right? That would be dumb. It’s extremely sensitive information. And yet, the consumer genetic testing market ...
